SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-162583
Filing Date
2017-05-08
Accepted
2017-05-08 16:10:47
Documents
47
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d378852d10q.htm 10-Q 558587
2 EX-31.1 d378852dex311.htm EX-31.1 6628
3 EX-31.2 d378852dex312.htm EX-31.2 6406
4 EX-32.1 d378852dex321.htm EX-32.1 4456
11 GRAPHIC g378852g04p79.jpg GRAPHIC 47568
  Complete submission text file 0001193125-17-162583.txt   2198098

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT drna-20170331.xml EX-101.INS 287188
6 XBRL TAXONOMY EXTENSION SCHEMA drna-20170331.xsd EX-101.SCH 26912
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drna-20170331_cal.xml EX-101.CAL 38247
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drna-20170331_def.xml EX-101.DEF 71195
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE drna-20170331_lab.xml EX-101.LAB 204132
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drna-20170331_pre.xml EX-101.PRE 139433
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 17822314
SIC: 2834 Pharmaceutical Preparations